{
    "nctId": "NCT06583655",
    "briefTitle": "Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer",
    "officialTitle": "A Prospective Study of Individualized Regional Node Irradiation for Sentinel Node-positive Breast Cancer Without Axillary Dissection Based on Clinical and Genomic Risk Assessment",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer Invasive",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 205,
    "primaryOutcomeMeasure": "Percentage of patients with arm lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 1. Histologically confirmed invasive breast cancer; 2. Age between 18 and 80 years; 3. cN0 breast cancer underwent radical surgery combined with Sentinel Lymph Node Dissection (SLND) alone with SLND positive or SLND and axillary lymph node dissection (ALND) with positive lymph node metastasis; 4. for SLND alone cohort, the regional lymph node irradiation area was determined according to the clinical risk model and genomic risk model assessment; 5. Ability to understand and willingness to participate the research and sign the consent form\n\nExclusion Criteria:\n\n* \u2022 Pathologically positive ipsilateral supraclavicular lymph node\n\n  * Pathologically or radiologically confirmed involvement of ipsilateral internal mammary lymph nodes;\n  * Pregnant or lactating women;\n  * Insulin dependent diabetes;\n  * History of non-breast malignancy within 5 years with the exception of lobular carcinoma in situ, basal cell carcinoma of the skin, carcinoma in situ of skin and carcinoma in situ of the cervix;\n  * patients have simultaneous contralateral breast cancer;\n  * clinical diagnosis of distant metastatic disease;\n  * Previous radiotherapy to the neck, chest and/or ipsilateral axillary region",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}